chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 13 year old male who on 09-DEC-1997 was vaccinated with the first dose of MMR II and on 05-SEP-2000 was vaccianted with the second dose of MMR II (lot numbers not reported). On 28-NOV-2009 the patient experienced mumps. On 08-DEC-2009 the patient was diagnosed. The patient was febrile at 102F. The patient had right parotitis. At the time of the report, the patient's status was unknown. Follow-up information was received which reported that the 13 (also reported as 12) year old patient on 02-JAN-2010 developed mumps. On 03-JAN-2010, the patient was diagnosed. Blood works were not conducted. At the time of the report, the patient's status was unknown. No further information is available.
Pt given Adult Hepatitis A vaccine 1st dose 08/02/07 2nd dose 09/11/2007
Rash all over hands, arms and chest area that appeared the next day and has remained. Also since the vaccine I have had no taste or smell.
Hives 2 different times, vomiting for 1 day, diarrhea since vaccine, headache for 7 weeks straight- no relief with medications, extreme fatigue, muscle pain/weakness
LOSS OF SENSATION IN 3 FINGERS IN ONE HAND; This spontaneous report received from a physician concerned an adult female. The patient's height, and weight were not reported. The patient's concurrent conditions included multiple sclerosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced loss of sensation in 3 fingers in one hand. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of loss of sensation in 3 fingers in one hand was not reported. This report was non-serious.  Additional information was received from patient on 24-Mar-2020 following information was updated and incorporated into case narrative:  Reporter updated; Patient's details updated; Reporter details updated.
This case was reported by a consumer via call center representative and described the occurrence of general body pain in a 66-year-old female patient who received SHINGRIX for prophylaxis. On 8th January 2019, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 9th January 2019, 1 days after receiving SHINGRIX, the patient experienced general body pain, fatigue, chills, fever and influenza-like symptoms. On 11th January 2019, the outcome of the general body pain, chills, fever and influenza-like symptoms were recovered/resolved. On 12th January 2019, the outcome of the fatigue was recovered/resolved. It was unknown if the reporter considered the general body pain, fatigue, chills, fever and influenza-like symptoms to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX vaccine on left deltoid and experienced flu-like symptoms which included fever of 101 degree F, chills, body aches. These symptoms started the next day after receiving the vaccine and lasted for approximately two days. The patient said she felt fatigued for one additional day after the other symptoms had resolved. The reporter gave permission for her physician to be contacted. The reporter unable to obtain additional information. For tolerance of 2nd dose refer linked case US2019GSK061316.
itchiness in throat, mild tongue swelling.   Administered Benadryl 50 mg.  sx resolved 5-6 minutes after medication administered
HORRIBLE PAIN IN RIGHT SHOULDER BLADE THAT RADIATES TO MY FOREARM - NOTHING ALLEVIATES THE PAIN AND HAVE BEEN TAKING 800 MG OF IBUPROFEN EVERY 6 HOURS SINCE PAIN STARTED.
I had very severe pain in both legs. This lasted for a few days before I ended up in the emergency room. They only drew labs and determined I did not have a blood clot. I'm taking ibuprofen and a baby aspirin but I do still have pain in both of my legs.
Oct 14- both legs and feet started tingling. Oct 17th-went to PCP B/C they wouldn't stop tingling. He did back X-ray which was negative to rule out back problems. Sent me to physical therapy because my insurance wouldn't cover MRI without it. PT didn't help. Oct 30-both arms started tingling too. Neurology consult ordered. Nov 17-got into neurologist who sent me directly to emergency room for lumbar puncture and was admitted for 5 days. Received IVIG. Still have neuropathy of arms and legs and feet to this day.
contact dermatitis on face and hands; This spontaneous case was reported by a physician and describes the occurrence of DERMATITIS CONTACT (contact dermatitis on face and hands) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced DERMATITIS CONTACT (contact dermatitis on face and hands). At the time of the report, DERMATITIS CONTACT (contact dermatitis on face and hands) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Doctor said that patient has a contact dermatitis from Poison Ivy on face and hands, would benefit by a course of oral steroid. Patient had first dose of vaccine 10 days ago, not immunosuppressed. Would we recommend he'd not do it or could is he do it without interfering the efficacy of the vaccine?  No concomitant were reported.
On 1/10/21, pt reported a rash.  It started on 1/5/21.  Pt described the rash as a pebbly, pimple-like rash all over the body, very itchy. She sought medical care and was put on a medrol dose pack. She had surgery on 1/5/21, the day the rash started and thought that perhaps it was a medication she may have received. But her daughter (immunized the same day) started to develop the same rash and they decided to contact us to report. Her daughter's rash started on 1/8/21. A separate VAERS  will be filed for her.
5JUL94 a rash appeared on cheeks; 6JUL94 rash was on the trunk & 7JUL94 there was a full body rash; rash was described as a fine red rash resembling a picture of measles (red); low grade temp; pt did not receive medical tx;
6 hours after receiving the vaccines the patient experienced violent vomiting, extreme weakness where he couldn't move his legs and nausea.
most everything smells like garbage and taste like it too; most everything smells like garbage and taste like it too; This spontaneous case was reported by a physician and describes the occurrence of TASTE DISORDER (most everything smells like garbage and taste like it too) and PAROSMIA (most everything smells like garbage and taste like it too) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 28-Feb-2021.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TASTE DISORDER (most everything smells like garbage and taste like it too) and PAROSMIA (most everything smells like garbage and taste like it too). At the time of the report, TASTE DISORDER (most everything smells like garbage and taste like it too) and PAROSMIA (most everything smells like garbage and taste like it too) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment information was reported
swelling on the joints; swelling on the hands and feet; Itchy rash; rash all over; redness and irritation on the left arm  where she received the vaccine; redness and irritation on the left arm  where she received the vaccine; Initial information received on 14-Sep-2020 regarding an unsolicited valid non-serious case received from a other health professional (Medical assistant).  This case involves a 4-year-old female patient who experienced itchy rash (rash pruritic), rash all over  (rash), swelling on the joints  (joint swelling), swelling on the hands and feet (peripheral swelling), redness and irritation on the left arm where patient received the vaccine (vaccination site erythema and vaccination site irritation), while she received vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL].  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccination included MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD) for Immunisation.  On 11-Sep-2020, the patient received a fifth dose of 0.5 ml of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE (lot C5635AA and expiry date: not reported:18-Jun-2021) via an intramuscular route in the left arm for prophylactic vaccination.  On 11-Sep-2020, the patient developed a non-serious itchy rash (rash pruritic), rash all over (rash), swelling on the joints  (joint swelling), swelling on the hands and feet (peripheral swelling), redness and irritation on the left arm where patient received the vaccine (vaccination site erythema and vaccination site irritation), on same day following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE.  Details of laboratory data not reported.    It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event rash pruritic, rash, joint swelling, peripheral swelling, vaccination site erythema and vaccination site irritation was reported as unknown.
Apparent seizure ( whole body shaking, arms and legs involved, foaming @ mouth. lasted 1-2 mins. 45 min after immunizations given. In car seat, taken directly to ER
Lethargic from birth, no appetite, jaundice. From day 4 after birth endless, shrill, inconsolable screaming, day and night, 18 hours a day, for almost a week, then screamed 8 hours a day until 9 weeks old. Encephalitis caused by hepatitis B vaccine given when a few hours old. Autism diagnosed when 20 months old.
Bilateral knee pain, with no prior history of knee injury. Weakness in right knee as well.
Headache; Fatigue; Dry mouth; Blurry vision/ worse in one eye than the other; Face swelling; Red puncta rash on external & internal eye lids; Vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL9264) via an unspecified route of administration in the right arm on 08Apr2021 at 08:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included allergy to cephalosporins. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included daily intake of multivitamin (MANUFACTURER UNKNOWN) and biotin (MANUFACTURER UNKNOWN); both for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6204) via an unspecified route of administration in the right arm on 16Mar2021 at 08:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 09:30, the patient experienced headache, fatigue, dry mouth for 48 hours, blurry vision for 1 hour (worse in one eye than the other), face swelling for 24 hours, red puncta rash on external and internal eye lids for 48 hours (may be due to vomiting). Since the vaccination, the patient had not been tested for COVID-19. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event blurry vision was resolved on 08Apr2021 at 10:30. The clinical outcome of the event swelling face was resolved on 09Apr2021 at 09:30. The clinical outcome of the events headache, fatigue, dry mouth and red puncta rash on external and internal eye lids was resolved on 10Apr2021 at 09:30. The clinical outcome of the event vomiting was resolved on an unspecified date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Dizziness, nausea, chills lasting 20-30 minutes  tightness in chest / light pain near heart, lump/swelling in throat lasting 5-6 hours then tapering down for the next 4 hours
Hives, itchy throat, watery- irritated eyes reported by patient after lunch 12:50pm.
Patient stated following vaccine, on her way home she began to have "hot feeling" in the back of her neck. She also had a funny feeling in her head. She drove herself to the ER, were she was monitored for 2 hours. No medication was given, no IV fluids and no reaction at injection site.
G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE 5/1/2023 ACUTE RESPIRATORY FAILURE    REACTIVE AIRWAY DISEASE, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 4/14/2023 ACUTE RESPIRATORY FAILURE    REACTIVE AIRWAY DISEASE, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/14/2023 ACUTE RESPIRATORY FAILURE    REACTIVE AIRWAY DISEASE, UNSPECIFIED
Started to feel Swelling in her throat; Tingling in Tongue; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Started to feel Swelling in her throat) and PARAESTHESIA ORAL (Tingling in Tongue) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced PHARYNGEAL SWELLING (Started to feel Swelling in her throat) and PARAESTHESIA ORAL (Tingling in Tongue). The patient was treated with DIPHENHYDRAMINE ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PHARYNGEAL SWELLING (Started to feel Swelling in her throat) and PARAESTHESIA ORAL (Tingling in Tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug information was not provided. Treatment information included Benadryl.
Site reaction. Red, swollen, hard and warm. Fever. Severe body aches, chills, shaking, cough, SOA, headache, fatigue.
"Covid/Vaccine arm" ~ very swollen, red, hot, itchy rash at injection site presented on day 8 after vaccination
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's medical history and concurrent conditions was provided. On an unknown date, the patient was vaccinated with a dose of PROQUAD, lot # M007961, expiration date: 15-AUG-2017, subcutaneously in the back of the arm, (dose and dose number were not specified). There were no concomitant medications reported. It was stated that the vaccine had undergone a temperature excursion (no further details provided). The patient did not experience any adverse reactions. At the time of the report, it was unknown if the patient continued to receive PROQUAD. This is one of several reports received from the same source. Additional information has been requested.
approx 10-15 min p/inj runny nose,throat tight,devel cough,itching in throat,feeling as if could not breathe,rt orbital edema,bilat inspiratory&expiratory wheezes;pulse 160,resp 24;pt observed while in ER&was observed&given DPH
got virus after 2 weeks; Got virus; This is a spontaneous report received from a non-contactable pharmacist via a Pfizer Sponsored Program. A female patient of an unspecified age received bnt162b2, Solution for injection (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient got virus 2 weeks later on an unspecified date. First time calling Pharmacist has a patient who received first vaccine and 2 weeks later got virus. She was asking how to proceed for the second vaccine. At this point lost the call and could hear her but she was unresponsive. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity with only first dose of the vaccine.
Patient was given the second dose of Pfizer vaccine 16 days after the first dose, 1 day earlier than the grace period.
Headache, Fever, UrticariaPruritus, Diarrhea, NauseaVomiting, fatigue, site pain and swelling Narrative:
Narrative: He had CVA 2 weeks after 2nd pfizer vaccine. He is now on lipitor QHS and ASA 81MG . He lost his ability to speak for 24 hours. He has no permanent deficits. Clinical decision-making: Plan: 1) CVA: continue lipitor and ASA 81, given the timing of the administration of the COVID vaccine that may be possibility that it was triggered by the vaccine. Patient has already completed both shots. Patient counseled to hold off on the booster shot until there is more date to determine impact of booster on recurrence of vascular events
Moderna Covid-19 vaccine administered to unauthorized age group.  Patient was only 17 years of age.  No reactions or symptoms to report.
myopericarditis, chest pain, elevated troponin, EKG changes, moderately decreased LV function (started 3 days after vaccine administration). treated with NSAIDs
1ST DOSE WAS A PFIZER VACCINE AND THE 2ND DOSE THAT WAS GIVEN WAS MODERNA
Severe neck and shoulder pain, low grade fever, restlessness, headache, dizziness, and no energy.
Sinus infection; there are allergies right now; I'm assuming she can't get the vaccine; This is a spontaneous report from a contactable pharmacist. A 15-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as 1st dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced sinus infection and assuming she can't get the vaccine, there are allergies right now on an unspecified date. The caller stated have a patient (female age unsure maybe 15 years) who was coming this friday for her vaccination and she had a sinus infection and on antibiotics. Pharmacist was assuming she can't get the vaccine. How long does she need to wait? It was her 2nd dose on Friday which will be at 3 weeks. She already got her first dose of the Pfizer covid vaccine. Pharmacist stated she need to talk to her patient more to find out if she was on any steroids and when her antibiotics ends. It makes sense to her that the immune system was fighting the infection. Caller stated she did not think the sinus infection was related (sounds like it was independent) to the Pfizer covid vaccine but she stated she will need to talk to her more and get more information from her patient. She stated she thinks she got the infection last week and she got her first dose of the Pfizer covid vaccine almost 3 weeks ago. She said in the withheld (where she was located) there are allergies right now. Therapeutic measures were taken as a result of sinus infection which include antibiotics. The outcome for event sinus infection was not recovered and rest of events outcome was unknown.  Information on Batch/Lot Number has been requested.; Sender's Comments: Based on the information available and a close temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events of  Sinusitis, hypersensitivity. The case will be reassessed once new information is available.
Rapid onset of fever 103.7 orally, headache, dry heaves, took two extra strenght Tylenol 1000 mg. 3L fluids over three hours, water and tea, bed rest. Fever broke @ 2300 excessive sweating fever did not return, temp @ 1430 98.9. No appetite, dry heaves during fever, after fever broke tired and went to bed
He stated he was feeling ill, then became pale clammy and unresponsive.  He stopped breathing and was convulsing.  He got him to the store safely, took his pulse and blood pressure and kept him still until EMS arrived.  EMS was called and checked him out.
Vomiting x 1 every night and 5 loose stools per day (reported to PCP 1 month after vaccine).
Fever 102.8, chills, sore arm, nausea, fatigue, body aches.  Symptoms lasted 3 days.  Took Ibuprofen, didn't help.
This client received VZV vaccine on 03/29/01. The sister of the client received VZV vaccine at the doctors off on 11/11/98. The doctor confirmed both children developed varicella on 04/10/01. The mother indicated the children were not exposed to anyone with varicella.
Patient given wrong vaccine type. Provider ordered Meningococcal vaccine type Menactra. Patient given MenB type Bexsero instead. Staff error.